We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-21.98%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
$0
Cap. Flow
-$63.6K
Cap. Flow %
-0%
Top 10 Hldgs %
13.08%
Holding
3,173
New
–
Increased
3
Reduced
4
Closed
–

Top Buys

Rank Stock Value
1
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
+$51.9K
2
OVV icon
Ovintiv
OVV
+$14.7K
3
VANI icon
Vivani Medical
VANI
+$119

Top Sells

Rank Stock Value
1
BIP icon
Brookfield Infrastructure Partners
BIP
+$78.8K
2
TU icon
Telus
TU
+$37K
3
ODFL icon
Old Dominion Freight Line
ODFL
+$14.5K
4
BBBY
Bed Bath & Beyond
BBBY
+$11

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LM
2451
DELISTED
Legg Mason, Inc.
LM
$1K ﹤0.01%
34
– –
CRCM
2452
DELISTED
CARE.COM, INC.
CRCM
$1K ﹤0.01%
83
– –
DPLO
2453
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1K ﹤0.01%
420
– –
UCFC
2454
DELISTED
United Community Financial Corp
UCFC
$1K ﹤0.01%
149
– –
MYRX
2455
DELISTED
MYREXIS INC COM STK
MYRX
$1K ﹤0.01%
100,980
– –
KPN
2456
DELISTED
ROYAL KPN NV ADS (EA REPTG 1 ORD SH)
KPN
$1K ﹤0.01%
358
– –
TI
2457
DELISTED
Telecom Italia
TI
$1K ﹤0.01%
187
– –
DOC
2458
DELISTED
PHYSICIANS REALTY TRUST
DOC
$1K ﹤0.01%
102
– –
AAOI icon
2459
Applied Optoelectronics
AAOI
$7.56B
$0 ﹤0.01%
54
– –
ACB
2460
Aurora Cannabis
ACB
$172M
$0 ﹤0.01%
5
– –
ACRS icon
2461
Aclaris Therapeutics
ACRS
$714M
$0 ﹤0.01%
74
– –
AGYS icon
2462
Agilysys
AGYS
$2.98B
$0 ﹤0.01%
37
– –
AMRX icon
2463
Amneal Pharmaceuticals
AMRX
$5.75B
$0 ﹤0.01%
114
– –
ANGI icon
2464
Angi Inc
ANGI
$222M
$0 ﹤0.01%
2
– –
ATRC icon
2465
AtriCure
ATRC
$1.91B
$0 ﹤0.01%
29
– –
BBU
2466
DELISTED
Brookfield Business Partners
BBU
$0 ﹤0.01%
5
– –
BCDA icon
2467
BioCardia
BCDA
$12.2M
$0 ﹤0.01%
9
– –
BCO icon
2468
Brink's
BCO
$4.81B
$0 ﹤0.01%
9
– –
BLNK icon
2469
Blink Charging
BLNK
$74.5M
$0 ﹤0.01%
20
– –
BLX icon
2470
Bladex Inc
BLX
$2.2B
$0 ﹤0.01%
7
– –
BNED icon
2471
Barnes & Noble Education
BNED
$430M
$0 ﹤0.01%
1
– –
BUSE icon
2472
First Busey Corp
BUSE
$2.56B
$0 ﹤0.01%
36
– –
BBBY
2473
Bed Bath & Beyond
BBBY
$473M
$0 ﹤0.01%
17
-2
-11% -$11
CARS icon
2474
Cars.com
CARS
$646M
$0 ﹤0.01%
1
– –
CCM
2475
Concord Medical Services
CCM
$19.4M
$0 ﹤0.01%
30
– –
97 98
99
100 101

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q1 2020 Portfolio in Review

As of Q1 2020, Glenmede Trust held 3,173 positions worth $21.9B, unchanged from the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 0%. Glenmede Trust opened no new positions and made no exits, leaving the 3,173-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, unchanged from a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust added most to Interpace Biosciences, Inc. Common Stock in Q1 2020, an estimated $51.9K increase.
  • Glenmede Trust's biggest Q1 2020 reduction was Brookfield Infrastructure Partners, cutting an estimated $78.8K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q1 2020.
  • Glenmede Trust opened 0 new positions and closed 0 in Q1 2020.
  • Glenmede Trust's portfolio value was unchanged quarter-over-quarter at $21.9B.

Based on Glenmede Trust's 13F filing for Q1 2020, filed 20 May 2020.